| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.5B | $23.7B | $20.9B | $17.1B | $13.0B | $11.2B | $3.1B | $3.1B |
| Cost of Revenue | $24.2B | $20.2B | $17.9B | $14.5B | $11.0B | $9.5B | $10.5B | $9.7B |
| Gross Profit | $4.3B | $3.5B | $2.9B | $2.5B | $2.0B | $1.7B | $0.4B | $0.4B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.2B | $1.8B | $1.6B | $1.3B | $1.2B | $1.0B | $1.0B | $0.9B |
| Operating Income | $1.6B | $1.3B | $1.1B | $0.9B | $0.7B | $0.6B | $0.6B | $0.5B |
| Net Income | $1.0B | $0.9B | $0.7B | $0.5B | $0.5B | $0.4B | $0.4B | $0.1B |
| EPS (Basic) | $6.91 | $6.16 | $5.13 | $3.42 | $3.45 | $3.15 | $2.76 | $1.92 |
| EPS (Diluted) | $6.80 | $6.03 | $5.00 | $3.32 | $3.34 | $3.07 | $2.73 | $1.90 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $24.9B | $18.7B | $16.2B | $13.5B | $12.9B | $8.4B | $8.3B | $7.1B |
| Current Assets | $9.9B | $7.9B | $7.7B | $5.5B | $4.7B | $3.6B | $3.8B | $3.3B |
| Cash & Equivalents | $0.4B | $0.7B | $1.3B | $0.4B | $0.2B | $0.2B | $0.2B | $0.1B |
| Total Liabilities | $15.9B | $11.4B | $10.0B | $8.1B | $7.7B | $4.0B | $4.3B | $3.5B |
| Current Liabilities | $8.7B | $6.0B | $5.2B | $3.4B | $3.2B | $2.1B | $2.3B | $1.8B |
| Stockholders' Equity | $8.9B | $7.3B | $6.3B | $5.4B | $5.1B | $4.3B | $4.1B | $3.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.2B | $2.1B | $1.6B | $1.1B | $0.6B | $1.1B | $0.5B | — |
| Investing Cash Flow | $-3.8B | $-2.3B | $-1.0B | $-0.6B | $-2.9B | $-0.5B | $-0.6B | — |
| Capital Expenditures | $0.6B | $0.6B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| Financing Cash Flow | $1.3B | $-0.3B | $0.3B | $-0.3B | $2.4B | $-0.6B | $0.2B | — |